Evidence map›Paper›PMID 33493579›Full record

ArticleDiabetes research and clinical practice2021

The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes.

Mohamed Hassanein, Zanariah Hussein, Inass Shaltout, Wan Juani Wan Seman, Chin Voon Tong, Nurain Mohd Noor, Mehmet Akif Buyukbese, Lobna El Tony, Gamal Mohamed Shaker, Reem M Alamoudi and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Improving knowledge on the management of diabetes mellitus during Ramadan.Journal of Taibah University Medical Sciences · 2025
    Article
  8. Review
  9. Review
  10. Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ramadan Fasting and Changes in Thyroid Function in Hypothyroidism: Identifying Patients at Risk.Thyroid : official journal of the American Thyroid Association · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 14 institutions in 9 countries.

Mohamed HassaneinDubai Hospital, DHA, United Arab Emirates; Gulf Medical University, United Arab Emirates; Postgraduate Diabetes Education, Cardiff University, UK.
Zanariah HusseinDepartment of Internal Medicine, Hospital Putrajaya, Putrajaya, Malaysia. Electronic address: zanariahh@hotmail.com.
Inass ShaltoutDepartment of Internal Medicine, Hospital Melaka, Melaka, Malaysia.
Wan Juani Wan SemanDepartment of Internal Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
Chin Voon TongFaculty of Medicine, Cairo University, Cairo, Egypt.
Nurain Mohd NoorDepartment of Internal Medicine, Hospital Putrajaya, Putrajaya, Malaysia.
Mehmet Akif BuyukbeseMedistate Kavacik Hospital, Internal Medicine Department, Istanbul, Turkey.
Lobna El TonyAssiut University, Egypt.
Gamal Mohamed ShakerStrategic Data Analysis, Research and Studies Department Dubai Health Authority, United Arab Emirates. Electronic address: gmibrahim@dha.gov.ae.
Reem M AlamoudiDepartment of Medicine, King Abdulaziz Medical City, King Saud Bin Abdulaziz University for Health Sciences, King Abdullah International Research Center, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia. Electronic address: amoudir@ngha.med.sa.
Khadija HafidhRashid Hospital, Diabetes Unit, Dubai Health Authority, United Arab Emirates. Electronic address: kahafidh@dha.gov.ae.
M FariduddinDepartment of Endocrinology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.
Mohammed A BataisDiabetes & Chronic Disease Management, Department of Family and Community Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Shehla ShaikhSaifee Hospital, India.
Pr Rachid MalekInternal Médecine, CHU, Setif 19000, Algeria.
Majid AlabboodAlzahraa College of Medicine, University of Basra, Iraq.
Rakesh SahayDepartment of Endocrinology, Osmania Medical College & Osmania General Hospital, Hyderabad, India.
Abdulwadod M AlshenqeteNutrition Department, King Fahd Hospital, Madinah Munawarah, Saudi Arabia.
Muhammad Yakoob AhmedaniBaqai Institute of Diabetology & Endocrinology (BIDE)/Baqai Medical University (BMU), Pakistan. Electronic address: myakoob@bide.edu.pk.
Assiut University · EGBangabandhu Sheikh Mujib Medical University · BDBaqai Institute of Diabetology and Endocrinology · PKCairo University · EGCentre Hospito Universitaire de Sétif · DZDubai Health Authority · AEGulf Medical University · AEKing Fahad Hospital Jeddah · SAKing Saud University · SAMalacca General Hospital · MYNational Guard Health Affairs · SAOsmania General Hospital · INRashid Hospital · AESaifee Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe DAR Global survey of Ramadan-fasting during the COVID-19 pandemic aimed to describe the characteristics and care in participants with type 2 diabetes (T2D) with a specific comparison between those <65 years and ≥65 years.

methodsParticipants were consented to answer a physician-administered questionnaire following Ramadan 2020. Impact of COVID-19 on the decision of fasting, intentions to fast and duration of Ramadan and Shawal fasting, hypoglycaemia and hyperglycaemia events were assessed. Specific analysis comparing age categories of <65 years and ≥65 years were performed.

resultsAmong the 5865 participants, 22.5% were ≥65 years old. Concern for COVID-19 affected fasting decision for 7.6% (≥65 years) vs 5.4% (<65 years). More participants ≥65 years old did not fast (28.8% vs 12.7%, <65 years). Of the 83.6%, participants fulfilling Ramadan-fasting, 94.8% fasted ≥15 days and 12.6% had to break fast due to diabetes-related illness. The average number of days fasting within and post-Ramadan were 27 and 6 days respectively, regardless of age. Hypoglycaemia and hyperglycaemia occurred in 15.7% and 16.3% of participants respectively, with 6.5% and 7.4% requiring hospital care respectively. SMBG was performed in 73.8% of participants and 43.5% received Ramadan-focused education.

conclusionDuring the COVID-19 pandemic, universally high rates of Ramadan-fasting were observed regardless of fasting risk level. Glycemic complications occurred frequently with older adults requiring higher rates of acute hospital care. Risk stratification is essential followed by pre-Ramadan interventions, Ramadan-focused diabetes education and self-monitoring to reduce and prevent complications, with particular emphasis in older adults.

Indexed as

IslamAdultAgedAged, 80 and overAge FactorsAgingBlood GlucoseCOVID-19Cross-Sectional StudiesDiabetes Mellitus, Type 2FastingFemaleHealth Knowledge, Attitudes, PracticeHumansHypoglycemic AgentsMaleBlood GlucoseHypoglycemic Agents

Identifiers

PMID33493579
PMCPMC7826018
OpenAlexW3125144771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.